RECRUITINGINTERVENTIONAL
CHEST-CA: Study of Chest Pain and Hidden Cardiac Amyloidosis
About This Trial
The objective of this observational, prospective study is to determine the prevalence of Cardiac Amyloidosis (CA) in males over the age of 65 who experience chest pain but show no signs of coronary artery disease (CAD). Prior to inclusion, all patients will have undergone a CT coronary angiogram or an Rb-PET scan to rule out the possibility of CAD. Participants will be subject to several examinations, including blood tests, urine samples, ECG, echocardiography, and bone scintigraphy. An endomyocardial biopsy may be conducted if necessary.
Who May Be Eligible (Plain English)
Who May Qualify:
No signs of CAD through Rb-PET and/or CT coronary arteriogram
Who Should NOT Join This Trial:
Previous history of amyloidosis
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
No signs of CAD through Rb-PET and/or CT coronary arteriogram
Exclusion Criteria:
Previous history of amyloidosis
Treatments Being Tested
OTHER
Screening thourgh examinations including bonescintigraphy
Clinical examination, blood samples, echo, bone scintigraphy
Locations (1)
Rigshospitalet
Copenhagen, Denmark